Literature DB >> 9724652

TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB.

A Yamit-Hezi1, R Dikstein.   

Abstract

The transcription factor NF-kappaB is important for expression of genes involved in immune responses, viral infections, cytokine signaling and stress. In addition NF-kappaB plays a crucial role in protecting cells from TNF-alpha-induced apoptotic stimuli, presumably by activating anti-apoptotic genes. Here we report that the sub-stoichiometric TFIID subunit TAFII105 is essential for activation of anti-apoptotic genes in response to TNF-alpha, serving as a transcriptional coactivator for NF-kappaB. The putative coactivator domain of TAFII105 interacts with the activation domain of the p65/RelA member of the NF-kappaB family, and further stimulates p65-induced transcription in human 293 cells. Moreover, inhibition of TAFII105 activity by overexpression of a dominant negative mutant of TAFII105 decreased NF-kappaB transcriptional activity and severely reduced cell survival in response to TNF-alpha. Similarly, expression of anti-sense TAFII105 RNA sensitized the cells to TNF-alpha cytotoxicity. These results suggest that TAFII105 is involved in activation of anti-apoptotic genes by NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724652      PMCID: PMC1170844          DOI: 10.1093/emboj/17.17.5161

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

Review 1.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

Authors:  I M Verma; J K Stevenson; E M Schwarz; D Van Antwerp; S Miyamoto
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

2.  Transcription activation in cells lacking TAFIIS.

Authors:  S S Walker; J C Reese; L M Apone; M R Green
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

Review 3.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

Review 4.  Rel/NF-kappa B/I kappa B story.

Authors:  S Miyamoto; I M Verma
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

Review 5.  Multi-step activation of NF-kappa B/Rel transcription factors.

Authors:  M L Schmitz; P A Baeuerle
Journal:  Immunobiology       Date:  1995-07       Impact factor: 3.144

6.  Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors.

Authors:  M May; G Mengus; A C Lavigne; P Chambon; I Davidson
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

7.  Multiple TAFIIs directing synergistic activation of transcription.

Authors:  F Sauer; S K Hansen; R Tjian
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

8.  DNA template and activator-coactivator requirements for transcriptional synergism by Drosophila bicoid.

Authors:  F Sauer; S K Hansen; R Tjian
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

9.  The glutamine-rich activation domains of human Sp1 do not stimulate transcription in Saccharomyces cerevisiae.

Authors:  A S Ponticelli; T S Pardee; K Struhl
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators.

Authors:  C M Chiang; R G Roeder
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

View more
  21 in total

1.  The human TFIID components TAF(II)135 and TAF(II)20 and the yeast SAGA components ADA1 and TAF(II)68 heterodimerize to form histone-like pairs.

Authors:  Y G Gangloff; S Werten; C Romier; L Carré; O Poch; D Moras; I Davidson
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

4.  C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genes.

Authors:  Ido Paz-Priel; Simone Houng; Julia Dooher; Alan D Friedman
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

5.  TAF4 inactivation in embryonic fibroblasts activates TGF beta signalling and autocrine growth.

Authors:  Gabrielle Mengus; Anas Fadloun; Dominique Kobi; Christelle Thibault; Lucia Perletti; Isabelle Michel; Irwin Davidson
Journal:  EMBO J       Date:  2005-07-14       Impact factor: 11.598

Review 6.  Genome reading by the NF-κB transcription factors.

Authors:  Maria Carmen Mulero; Vivien Ya-Fan Wang; Tom Huxford; Gourisankar Ghosh
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

7.  Prodos is a conserved transcriptional regulator that interacts with dTAF(II)16 in Drosophila melanogaster.

Authors:  A Hernández-Hernández; A Ferrús
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

8.  Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.

Authors:  A C Lavigne; G Mengus; Y G Gangloff; J M Wurtz; I Davidson
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

9.  Core promoter binding by histone-like TAF complexes.

Authors:  Hanshuang Shao; Merav Revach; Sandra Moshonov; Yael Tzuman; Kfir Gazit; Shira Albeck; Tamar Unger; Rivka Dikstein
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

10.  Estrogen responsiveness of the TFIID subunit TAF4B in the normal mouse ovary and in ovarian tumors.

Authors:  Jennifer R Wardell; Kendra M Hodgkinson; April K Binder; Kimberly A Seymour; Kenneth S Korach; Barbara C Vanderhyden; Richard N Freiman
Journal:  Biol Reprod       Date:  2013-11-14       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.